Insider Trading Summary for Kiniksa Pharmaceuticals International, Plc (KNSA): Three Months

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
04-Sep-24 8:55 PM View:	02-Sep-24 Payment of Exercise ($84.95K)	Patel Sanj K Chairman & CEO Director		Kiniksa Pharmaceuticals International, Plc - KNSA	7% 177.45K to 189.35K	0	0	--	--	Show Txns Hide Txns

08-Oct-24 4:40 PM View:	04-Oct-24 Payment of Exercise ($2.01K)	Megna Michael R Chief Accounting Officer		Kiniksa Pharmaceuticals International, Plc - KNSA	19% 22.25K to 26.53K	0	0	--	--	Show Txns Hide Txns

08-Oct-24 4:14 PM View:	04-Oct-24 Grant 0	Baker Bros Advisors LLC Director		Kiniksa Pharmaceuticals International, Plc - KNSA	0% 2.86M to 2.87M	0	0	--	--	Show Txns Hide Txns

20-Nov-24 4:39 PM View:	18-Nov-24 Sale (Planned) ($147.28K)	Tessari Eben Chief Operating Officer		Kiniksa Pharmaceuticals International, Plc - KNSA	(19%) 127.41K to 102.97K	0	0	--	--	Show Txns Hide Txns

04-Sep-24 8:42 PM View:	03-Sep-24 Planned Option Sale ($1.79M)	Moat Ross Chief Commercial Officer		Kiniksa Pharmaceuticals International, Plc - KNSA	18% 18.39K to 21.74K	0	0	--	--	Show Txns Hide Txns

04-Sep-24 8:52 PM View:	03-Sep-24 Planned Option Sale ($1.58M)	Paolini John Chief Medical Officer		Kiniksa Pharmaceuticals International, Plc - KNSA	6% 49.02K to 52.04K	0	0	--	--	Show Txns Hide Txns

04-Sep-24 8:51 PM View:	02-Sep-24 Payment of Exercise ($25.56K)	Ragosa Mark Chief Financial Officer		Kiniksa Pharmaceuticals International, Plc - KNSA	16% 19.87K to 22.96K	0	0	--	--	Show Txns Hide Txns

Buy:	0	--
Sell:	0	--